Abbott receives FDA approval for Healon EndoCoat protective gel for cataract surgery
3 July 2012 | By Abbott
Abbott has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs)...
List view / Grid view
3 July 2012 | By Abbott
Abbott has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs)...
3 July 2012 | By HORIBA Scientific
HORIBA Scientific, organizes its first Technology Seminar focused on Life Sciences...
3 July 2012 | By FTI Consulting
The European Commission has adopted a legally binding decision in favour of granting of marketing authorisations for flutiform®...
2 July 2012 | By GlaxoSmithKline
Agreement reached with the US Government...
Lonza, a world leader in biopharmaceutical development technologies, announced today the addition of two new host organisms and their associated systems to its XS Technology™ Platform. The expanded XS Technology™ Toolbox addresses the diversity of microbially-derived proteins by providing complementary expression systems that quickly deliver simple, reliable, high yielding cGMP…
2 July 2012 | By Novo Nordisk
Novo Nordisk awarded the red dot Best of the Best prize for its next-generation insulin injection pen, the NovoPen® 5...
2 July 2012 | By GlaxoSmithKline
Results from the pivotal efficacy studies...
2 July 2012 | By TSI
The latest innovation in rapid microbiology method instrument technology is real-time viable detectors...
30 June 2012 | By AstraZeneca
Bristol-Myers Squibb to acquire Amylin...
29 June 2012 | By kdm communications limited
Avacta Group has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space...
29 June 2012 | By Biogen Idec
Isis expands its rare disease franchise to include DM1...
29 June 2012 | By GlaxoSmithKline
Expiration is after HGS process bid deadline of 16 July...
29 June 2012 | By Daiichi Sankyo
A DPP-4 Inhibitor for Type 2 Diabetes Mellitus Originating from Japan...
28 June 2012 | By kdm communications limited
Syrris’ latest free flow chemistry and automated process chemistry seminars, held during May in Dinslaken, Germany...
28 June 2012 | By Gilead Sciences
Gilead Sciences has submitted a New Drug Application to the U.S. FDA for marketing approval of cobicistat...